adenosine receptor antagonist
Showing 1 - 25 of >10,000
Rectal Cancer Trial in New York (Etrumadenant (AB928), Radiation therapy, FOLFOX regimen)
Recruiting
- Rectal Cancer
- Etrumadenant (AB928)
- +3 more
-
New York, New York
- +2 more
Apr 10, 2022
Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)
Not yet recruiting
- Renal Cell Carcinoma
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
Spinal Cord Injuries, Myelopathy Trial in Cambridge (Istradefylline, low oxygen therapy)
Not yet recruiting
- Spinal Cord Injuries
- Myelopathy
- Istradefylline
- low oxygen therapy
-
Cambridge, MassachusettsSpaulding Rehabilitation Hospital
Jun 24, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Adenosine A2B Receptor Antagonist PBF-1129
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 1, 2023
ALS Trial in Gainesville (Consume 20mg of istradefylline, Low Oxygen therapy, Placebo counterpart to the istradefylline drug)
Recruiting
- ALS
- Consume 20mg of istradefylline
- +3 more
-
Gainesville, FloridaClinical and Translational Research Building
Jul 5, 2022
LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)
Not yet recruiting
- LARS - Low Anterior Resection Syndrome
-
Seoul, Jongro-gu, Korea, Republic ofSeoul National University Hospital
Dec 13, 2022
Receptor Blockade Trial in Fort Collins (Adenosine Triphosphate, Acetylcholine, Sodium Nitroprusside)
Completed
- Receptor Blockade
- Adenosine Triphosphate
- +8 more
-
Fort Collins, ColoradoHuman Performance and Clinical Research Laboratory
Jul 26, 2021
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville
Not yet recruiting
- Head and Neck Cancer
- +9 more
- Zimberelimab
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 9, 2022
Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)
Recruiting
- Safety Issues
- +2 more
- Proglumide
- Placebo
-
Washington, District of ColumbiaGeorgetown University
Dec 1, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)
Completed
- Epidermolysis Bullosa
- Serlopitant Tablet
- Placebo Oral Tablet
-
Redwood City, CaliforniaStanford University
Nov 30, 2022
Monitoring Drug Efficacy in Patients With Alzheimer's Disease
Recruiting
- Alzheimer Disease
- AChE inhibitor monotherapy
- AChE inhibitor and NMDA receptor antagonist combination therapy
-
Manila, Metro Manila, PhilippinesPhilippine General Hospital
Mar 24, 2023
Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Kineret 100 MG in 0.67 ML Prefilled Syringe
- +3 more
-
Frankfurt, GermanyUniversity Hospital Goethe University Frankfurt
Aug 23, 2022
Cough Trial (device, diagnostic test, procedure)
Not yet recruiting
- Cough
- Adenosine triphosphate (ATP) solution inhalation from nebuliser
- +7 more
- (no location specified)
Jan 26, 2023
Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,
Recruiting
- Sleep Initiation and Maintenance Disorders
- Stress Disorders, Posttraumatic
- Suvorexant
- Placebo
-
San Francisco, California
- +1 more
Nov 10, 2022
Asthma Trial in Barcelona (PBF-680, Placebo oral capsule)
Completed
- Asthma
- PBF-680
- Placebo oral capsule
-
Barcelona, SpainUnitat de Pneumologia Experimental
Sep 24, 2020
Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Placebo
- Ondansetron Injection
-
Montréal, Quebec, CanadaHôpital Sacré-Coeur de Montréal
Aug 22, 2022
PTSD Trial in San Francisco (CORT108297, Placebo)
Not yet recruiting
- PTSD
- CORT108297
- Placebo
-
San Francisco, CaliforniaSan Francisco VA Medical Center, San Francisco, CA
Jul 26, 2022
Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)
Recruiting
- Rotator Cuff Tendinitis
- Chronic Pain
- Ketalar
- NaCl 9%
-
Kristiansund, NorwayDepartment of Orthopedic Surgery, Kristiansund Hospital
Mar 15, 2022
Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- (no location specified)
Apr 3, 2023
Chronic Coronary Syndromes Trial in Marseille (blood samples)
Recruiting
- Chronic Coronary Syndromes
- blood samples
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Dec 20, 2021
COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Candesartan Cilexetil
- +3 more
-
Guntur, India
- +4 more
Mar 13, 2022
Cardiovascular Diseases, Vascular Dilation Trial in Worcester (Ifetroban Sodium, Placebo)
Recruiting
- Cardiovascular Diseases
- Vascular Dilation
- Ifetroban Sodium
- Placebo
-
Worcester, MassachusettsUniversity of Massachusetts Medical School
Feb 16, 2022
Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)
Not yet recruiting
- Depressive Disorder, Major
- Anxiety Disorder
- Nociceptin Receptor Antagonist
- Aversive stimuli
- (no location specified)
Nov 3, 2022